Mean achieved blood pressure in the two groups was 120.6 mm Hg in the intensive-treatment group and 132.1 mm Hg in the ...

Bayer will present three new prespecified subgroup analyses from the pivotal Phase III FINEARTS-HF cardiovascular outcomes trial investigating KERENDI ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

For 25 years, the Royal Australian College of GPs (RACGP) and Diabetes Australia have been working together to provide GPs and other members of the clinical team with the latest evidence-based ...

We need a health system that not only provides medication but also encourages a healthy lifestyle. Group empowerment, digital ...

1 Improving the understanding of risk can allow clinicians to better personalize treatment approaches or catch HCC early ...

Substance use disorders (SUDs) are a major public health concern, with opioid use disorder (OUD) and alcohol use disorder ...

The study is the first set of global estimates directly linking diabetes prevalence with treatment coverage over a ...

A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without ...

New research indicates that people with cardiovascular-kidney-metabolic syndrome may have a higher risk of developing ...

Scientists conducted a simulation study to estimate the impact of cardiovascular-kidney-metabolic (CKM) syndrome on cardiovascular disease (CVD) risk prediction. The study found that adults with ...